한글목차

진단 시장에서의 인공지능 동향 및 전망

세계 진단 시장에서 인공지능은 방사선, 종양학, 신경학 및 심장학, 흉부 및 폐, 병리학 시장에서의 비지니스 기회로 인해 유망한 시장으로 평가받고 있습니다. 세계 진단 시장에서의 인공지능 활용은 2023년부터 2028년까지 33.5%의 CAGR로 2028년까지 약 38억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 진단 비용 절감에 대한 수요 증가, 의료 분야의 기술 개발, 저비용 진단 구성요소에 대한 수요 증가입니다.

진단 시장에서의 인공지능 인사이트

• Lucintel의 예측에 따르면, 검사 정확도 헬스케어 진단을 위해 설계된 AI 기반 소프트웨어의 발전과 함께 환자의 의료 이미지를 해석하면서 진단 정확도를 크게 향상시키기 위한 AI 지원 및 클라우드 기반 강화된 진단 솔루션에 대한 요구가 증가함에 따라 예측 기간 동안 소프트웨어가 가장 높은 성장세를 보일 것으로 예상됩니다.
• 신경학 및 심장병학은 신경질환의 발병률 증가와 전 세계적으로 신경질환 치료에 가치 기반 치료를 채택하는 경향이 증가함에 따라 계속해서 가장 큰 부문이 될 것으로 예상됩니다.
• 북미는 전자건강기록(EHR), 원격의료 서비스 및 기타 디지털 헬스케어 솔루션의 보급과 AI 기반 진단 기기의 원활한 통합으로 인해 예측 기간 동안 가장 큰 지역으로 남을 것으로 보입니다.

이 보고서는 다음과 같은 11가지 주요 질문에 대한 답변을 담고 있습니다:

• Q1. 진단 시장에서 인공지능의 구성요소별(하드웨어, 소프트웨어, 서비스), 기술별(머신러닝, NLP, 컨텍스트 기반 컴퓨팅, 컴퓨터 비전), 진단 유형별(방사선학, 종양학, 신경학 및 심장학, 흉부 및 폐 병리학, 기타), 지역별(북미, 유럽, 아시아태평양, 기타 지역)로 가장 유망하고 높은 성장 기회가 있는 곳은 어디인가?
• Q2. 향후 성장이 가속화될 부문과 그 이유는?
• Q3. 성장 속도가 빠르다고 생각되는 지역과 그 이유는?
• Q4. 시장 역학에 영향을 미치는 주요 요인은 무엇인가? 시장의 주요 과제와 비지니스 리스크는 무엇인가?
• Q5. 이 시장에서의 비지니스 리스크와 경쟁 위협은 무엇인가?
• Q6. 이 시장의 새로운 트렌드와 그 이유는?
• Q7. 시장에서의 고객 수요 변화에는 어떤 것들이 있는가?
• Q8. 이 시장의 새로운 발전과 그 발전을 주도하고 있는 기업은?
• Q9. 이 시장의 주요 기업은? 그리고 주요 기업들은 어떤 전략적인 노력을 기울이고 있는가?
• Q10. 이 시장의 경쟁 제품에는 어떤 것들이 있으며, 소재 및 제품 대체에 따른 시장 점유율 하락의 위협은 어느 정도인가?
• Q11. 지난 5년간 어떤 M&A가 이루어졌고, 업계에 어떤 영향을 미쳤습니까?

목차

제1장 주요 요약

제2장 세계 진단 시장의 인공지능 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2017년부터 2028년까지 시장 동향과 예측 분석

• 거시경제 동향(2017-2022년)과 예측(2023-2028년)
• 세계 진단 시장의 인공지능 동향(2017-2022)과 예측(2023-2028)
• 컴포넌트별 세계 진단 시장의 인공지능
  • 하드웨어
  • 소프트웨어
  • 서비스
• 세계 진단 시장의 인공지능 기술별 분석
  • 머신러닝
  • NLP
  • 상황인식 컴퓨팅
  • 컴퓨터 비전
• 진단 유형별 세계 진단 시장의 인공지능
  • 방사선과
  • 종양학
  • 신경내과와 순환기 내과
  • 흉부와 폐
  • 병리학
  • 기타

제4장 2017년부터 2028년까지 지역별 시장 동향과 예측 분석

• 지역별 세계 진단 시장의 인공지능
• 북미의 진단 시장의 인공지능
• 유럽의 진단 시장의 인공지능
• 아시아태평양 진단 시장의 인공지능
• 기타 지역 진단 시장의 인공지능

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영상 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략적 분석

• 성장 기회 분석
  • 컴포넌트별 세계 진단 시장의 인공지능 성장 기회
  • 기술별 세계 진단 시장의 인공지능 성장 기회
  • 진단 유형별 세계 진단 시장의 인공지능 성장 기회
  • 지역별 세계 진단 시장의 인공지능 성장 기회
• 세계 진단 시장의 인공지능의 새로운 동향
• 전략적 분석
  • 신제품의 개발
  • 세계 진단 시장의 인공지능 능력 확대
  • 세계 진단 시장의 인공지능 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 유력 기업의 기업 개요

• General Electric
• Siemens
• Aidoc Medical
• AliveCor
• Imagen Technologies
• VUNO
• IDx Technologies
• NovaSignal Corporation
• Riverain Technologies
• Zebra Medical Vision

영문목차

Artificial Intelligence in the Diagnostic Market Trends and Forecast

The future of artificial intelligence in the global diagnostic market looks promising with opportunities in the radiology, oncology, neurology & cardiology, chest & lung, and pathology markets. The use of artificial intelligence in the global diagnostic market is expected to reach an estimated $3.8 billion by 2028 with a CAGR of 33.5% from 2023 to 2028. The major drivers for this market are increasing need to lower diagnostic expenses, technological developments in the healthcare sector, and rising demand for low-cost diagnostic components.

A more than 150-page report is developed to help in your business decisions.

Artificial Intelligence in the Diagnostic Market by Segment

The study includes trends and forecast for artificial intelligence in the global diagnostic market by component, technology, diagnosis type, and region as follows:

Artificial Intelligence in the Diagnostic Market by Component [Shipment Analysis by Value from 2017 to 2028]:

• Hardware
• Software
• Services

Artificial Intelligence in the Diagnostic Market by Technology [Shipment Analysis by Value from 2017 to 2028]:

• Machine Learning
• NLP
• Context-Aware Computing
• Computer Vision

Artificial Intelligence in the Diagnostic Market by Diagnosis Type [Shipment Analysis by Value from 2017 to 2028]:

• Radiology
• Oncology
• Neurology & Cardiology
• Chest & Lungs
• Pathology
• Others

Artificial Intelligence in the Diagnostic Market by Region [Shipment Analysis by Value from 2017 to 2028]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Artificial Intelligence Companies in the Diagnostic Market

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, artificial intelligence companies in the diagnostic market cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of artificial intelligence companies in the diagnostic market profiled in this report include:

• General Electric
• Siemens
• Aidoc Medical
• AliveCor
• Imagen Technologies
• VUNO
• IDx Technologies
• NovaSignal Corporation
• Riverain Technologies
• Zebra Medical Vision

Artificial Intelligence in the Diagnostic Market Insights

• Lucintel forecasts that software is expected to witness the highest growth over the forecast period due to advancement of AI-driven software designed for healthcare diagnosis in test accuracy, as well as increasing requirement for AI-enabled and cloud-centric enhanced diagnostic solutions to improve diagnostic accuracy significantly while interpreting medical imagery of patients.
• Neurology & cardiology will remain the largest segment due to rising incidence of neurological disorders and increasing trend of adopting value based care in treating the cases of neurological disorders across the globe.
• North America will remain the largest region over the forecast period due to widespread incorporation of electronic health records (EHRs), telehealth offerings, and additional digital healthcare solutions, as well as seamless integration of AI-driven diagnostic instruments.

Features of Artificial Intelligence in the Diagnostic Market

• Market Size Estimates: Artificial intelligence in the diagnostic market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2017 to 2022) and forecast (2023 to 2028) by various segments and regions.
• Segmentation Analysis: Artificial intelligence in the diagnostic market size by various segments, such as by component, technology, diagnosis type, and region in terms of value ($B).
• Regional Analysis: Artificial intelligence in the diagnostic market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different components, technologies, diagnosis types, and regions for artificial intelligence in the diagnostic market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of artificial intelligence in the diagnostic market.
• Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

• Q1. What is artificial intelligence in the diagnostic market size?
• Answer: The use of artificial intelligence in the global diagnostic market is expected to reach an estimated $3.8 billion by 2028.
• Q2.What is the growth forecast for artificial intelligence in the diagnostic market?
• Answer: The use of artificial intelligence in the global diagnostic market is expected to grow with a CAGR of 33.5% from 2023 to 2028.
• Q3.What are the major drivers influencing the growth of artificial intelligence in the diagnostic market?
• Answer: The major drivers for this market are increasing need to lower diagnostic expenses, technological developments in the healthcare sector, and rising demand for low-cost diagnostic components.
• Q4. What are the major segments for artificial intelligence in the diagnostic market?
• Answer: The future of artificial intelligence in the diagnostic market looks promising with opportunities in the radiology, oncology, neurology & cardiology, chest & lung, and pathology markets.
• Q5. Who are the key artificial intelligence companies in the diagnostic market?
• Answer: Some of the key artificial intelligence companies in the diagnostic market are as follows:
  • General Electric
  • Siemens
  • Aidoc Medical
  • AliveCor
  • Imagen Technologies
  • VUNO
  • IDx Technologies
  • NovaSignal Corporation
  • Riverain Technologies
  • Zebra Medical Vision
• Q6. Which segment in the diagnostic market in terms of artificial Intelligence usage will be the largest in future?
• Answer: Lucintel forecasts that software is expected to witness the highest growth over the forecast period due to advancement of AI-driven software designed for healthcare diagnosis in test accuracy, as well as increasing requirement for AI-enabled and cloud-centric enhanced diagnostic solutions to improve diagnostic accuracy significantly while interpreting medical imagery of patients.
• Q7. In the diagnostic market in terms of artificial Intelligence usage, which region is expected to be the largest in next 5 years?
• Answer: North America will remain the largest region over the forecast period due to widespread incorporation of electronic health records (EHRs), telehealth offerings, and additional digital healthcare solutions, as well as seamless integration of AI-driven diagnostic instruments.
• Q.8. Do we receive customization in this report?
• Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

• Q1. What are some of the most promising, high-growth opportunities for artificial intelligence in the diagnostic market by component (hardware, software, and services), technology (machine learning, NLP, context-aware computing, computer vision), diagnosis type (radiology, oncology, neurology & cardiology, chest & lungs, pathology, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Artificial Intelligence in the Global Diagnostic Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

• 3.1: Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
• 3.2: Artificial Intelligence in the Global Diagnostic Market Trends (2017-2022) and Forecast (2023-2028)
• 3.3: Artificial Intelligence in the Global Diagnostic Market by Component
  • 3.3.1: Hardware
  • 3.3.2: Software
  • 3.3.3: Services
• 3.4: Artificial Intelligence in the Global Diagnostic Market by Technology
  • 3.4.1: Machine Learning
  • 3.4.2: NLP
  • 3.4.3: Context-Aware Computing
  • 3.4.4: Computer Vision
• 3.5: Artificial Intelligence in the Global Diagnostic Market by Diagnosis Type
  • 3.5.1: Radiology
  • 3.5.2: Oncology
  • 3.5.3: Neurology & Cardiology
  • 3.5.4: Chest & Lungs
  • 3.5.5: Pathology
  • 3.5.6: Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

• 4.1: Artificial Intelligence in the Global Diagnostic Market by Region
• 4.2: Artificial Intelligence in the North American Diagnostic Market
  • 4.2.1: Artificial Intelligence in the North American Diagnostic Market by Component: Hardware, Software, and Services
  • 4.2.2: Artificial Intelligence in the North American Diagnostic Market by Diagnosis Type: Radiology, Oncology, Neurology & Cardiology, Chest & Lungs, Pathology, and Others
• 4.3: Artificial Intelligence in the European Diagnostic Market
  • 4.3.1: Artificial Intelligence in the European Diagnostic Market by Component: Hardware, Software, and Services
  • 4.3.2: Artificial Intelligence in the European Diagnostic Market by Diagnosis Type: Radiology, Oncology, Neurology & Cardiology, Chest & Lungs, Pathology, and Others
• 4.4: Artificial Intelligence in the APAC Diagnostic Market
  • 4.4.1: Artificial Intelligence in the APAC Diagnostic Market by Component: Hardware, Software, and Services
  • 4.4.2: Artificial Intelligence in the APAC Diagnostic Market by Diagnosis Type: Radiology, Oncology, Neurology & Cardiology, Chest & Lungs, Pathology, and Others
• 4.5: Artificial Intelligence in the ROW Diagnostic Market
  • 4.5.1: Artificial Intelligence in the ROW Diagnostic Market by Component: Hardware, Software, and Services
  • 4.5.2: Artificial Intelligence in the ROW Diagnostic Market by Diagnosis Type: Radiology, Oncology, Neurology & Cardiology, Chest & Lungs, Pathology, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for Artificial Intelligence in the Global Diagnostic Market by Component
  • 6.1.2: Growth Opportunities for Artificial Intelligence in the Global Diagnostic Market by Technology
  • 6.1.3: Growth Opportunities for Artificial Intelligence in the Global Diagnostic Market by Diagnosis Type
  • 6.1.4: Growth Opportunities for Artificial Intelligence in the Global Diagnostic Market by Region
• 6.2: Emerging Trends of Artificial Intelligence in the Global Diagnostic Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of Artificial Intelligence in the Global Diagnostic Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures of Artificial Intelligence in the Global Diagnostic Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: General Electric
• 7.2: Siemens
• 7.3: Aidoc Medical
• 7.4: AliveCor
• 7.5: Imagen Technologies
• 7.6: VUNO
• 7.7: IDx Technologies
• 7.8: NovaSignal Corporation
• 7.9: Riverain Technologies
• 7.10: Zebra Medical Vision